Nancy Valente

Insider Reports History

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, 9 Th Floor, Brisbane, CA
Signature
/s/ Celia E. Eckert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Valente:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xencor Inc EVP, Chief Development Officer Common Stock 55.1K $1.3M $23.58 May 2, 2024 Direct
Xencor Inc EVP, Chief Development Officer Stock Options 118K Mar 5, 2024 Direct
Myovant Sciences Ltd. Director Common Shares 0 $27.00 Mar 10, 2023 Direct
Myovant Sciences Ltd. Director Stock Options (Right to Buy) 0 Mar 10, 2023 Direct

Insider Reports Filed by Nancy Valente

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XNCR Xencor Inc May 2, 2024 1 -$112K 4 May 3, 2024 EVP, Chief Development Officer
XNCR Xencor Inc Mar 5, 2024 2 $0 4 Mar 7, 2024 EVP, Chief Development Officer
XNCR Xencor Inc May 1, 2023 2 $0 4 May 3, 2023 EVP, Chief Development Officer
MYOV Myovant Sciences Ltd. Mar 10, 2023 2 $0 4 Mar 10, 2023 Director
MYOV Myovant Sciences Ltd. Oct 26, 2022 1 $0 4 Oct 28, 2022 Director
XNCR Xencor Inc Sep 8, 2022 1 $0 4 Sep 9, 2022 Director
XNCR Xencor Inc Sep 8, 2022 0 $0 3 Sep 9, 2022 Director
MYOV Myovant Sciences Ltd. Nov 5, 2021 1 $0 4 Nov 9, 2021 Director
MYOV Myovant Sciences Ltd. Nov 5, 2021 0 $0 3 Nov 9, 2021 Director